• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C 反应蛋白白蛋白比值可能预测行经皮冠状动脉介入治疗的隐静脉桥狭窄患者无复流。

CRP Albumin Ratio May Predict No Reflow in Patients Undergoing Percutaneous Coronary Intervention for Saphenous Vein Graft Stenosis.

机构信息

Department of Cardiology, Tokat State Hospital, Tokat, Turkey.

Public Health Department, Tokat Provincial Health Directorate, Tokat, Turkey.

出版信息

Angiology. 2023 Jan;74(1):55-61. doi: 10.1177/00033197221098277. Epub 2022 May 2.

DOI:10.1177/00033197221098277
PMID:35500071
Abstract

Many hypotheses have been proposed to explain no-reflow (NR). Some of these hypotheses, state that NR may be caused by damage to the vascular endothelium and an inflammatory process. In a recent study that did not include patients with coronary artery bypass graft (CABG), the ratio of C-reactive protein (CRP) to albumin (CAR) was found to be associated with NR. Our study aims to evaluate the relationship between CAR and NR in patients who underwent percutaneous coronary intervention (PCI) for saphenous vein graft (SVG). In this retrospective study, among the patients with CABG who underwent primary or elective coronary angiography, 242 patients who underwent PCI to the SVG were selected. The incidence of NR was 19.8% (n = 48). Diabetes mellitus, left ventricular ejection fraction (LVEF), stent length, and CAR were found as independent predictors of NR in multivariate logistic regression analysis (P < .05). Using a cut-off level of .930, the CAR predicted NR with a sensitivity of 75% and a specificity of 73% (AUC: .814, 95% CI: .749-.879, P < .001). The CAR was a better predictor than both stent length and LVEF. CAR was found to be the strongest predictor of NR in our study.

摘要

许多假说被提出以解释无复流(NR)现象。其中一些假说认为,NR 可能是由血管内皮损伤和炎症过程引起的。在一项最近的研究中,该研究未包括冠状动脉旁路移植术(CABG)患者,发现 C 反应蛋白(CRP)与白蛋白(ALB)的比值(CAR)与 NR 相关。我们的研究旨在评估经皮冠状动脉介入治疗(PCI)治疗大隐静脉桥(SVG)患者中 CAR 与 NR 之间的关系。在这项回顾性研究中,在接受 CABG 行初次或选择性冠状动脉造影的患者中,选择了 242 例行 PCI 至 SVG 的患者。NR 的发生率为 19.8%(n=48)。多变量逻辑回归分析发现,糖尿病、左心室射血分数(LVEF)、支架长度和 CAR 是 NR 的独立预测因子(P<.05)。使用.930 的截断水平,CAR 预测 NR 的敏感度为 75%,特异度为 73%(AUC:.814,95%CI:.749-.879,P<.001)。CAR 比支架长度和 LVEF 更能预测 NR。在我们的研究中,CAR 被发现是预测 NR 的最强预测因子。

相似文献

1
CRP Albumin Ratio May Predict No Reflow in Patients Undergoing Percutaneous Coronary Intervention for Saphenous Vein Graft Stenosis.C 反应蛋白白蛋白比值可能预测行经皮冠状动脉介入治疗的隐静脉桥狭窄患者无复流。
Angiology. 2023 Jan;74(1):55-61. doi: 10.1177/00033197221098277. Epub 2022 May 2.
2
Assessment of systemic immune-inflammation index as an independent surrogate biomarker of no-reflow phenomenon in acute coronary syndrome patients with coronary artery bypass grafting undergoing percutaneous coronary intervention of saphenous vein graft.评估全身免疫炎症指数作为行隐静脉移植血管经皮冠状动脉介入治疗的急性冠状动脉综合征冠状动脉搭桥患者无复流现象的独立替代生物标志物。
Eur Rev Med Pharmacol Sci. 2023 Mar;27(6):2394-2403. doi: 10.26355/eurrev_202303_31774.
3
Intravascular ultrasound analysis of plaque characteristics and postpercutaneous coronary intervention catheterization outcomes according to the remodeling pattern in narrowed saphenous vein grafts.根据狭窄的隐静脉桥的重塑模式进行血管内超声分析斑块特征和经皮冠状动脉介入治疗后的导管插入术结果。
Am J Cardiol. 2012 Nov 1;110(9):1290-5. doi: 10.1016/j.amjcard.2012.06.031. Epub 2012 Jul 25.
4
Relationship between systemic immune-inflammation index and no-reflow in percutaneous coronary intervention for saphenous grafts.系统免疫炎症指数与经皮冠状动脉介入治疗隐静脉桥无复流的关系。
Biomark Med. 2023 Apr;17(8):427-435. doi: 10.2217/bmm-2023-0208. Epub 2023 Jul 14.
5
Intra-graft abciximab and verapamil combined with direct stenting is a safe and effective strategy to prevent slow-flow and no-reflow phenomenon in saphenous vein graft lesions not associated with thrombus.在不伴有血栓的隐静脉移植物病变中,移植物内使用阿昔单抗和维拉帕米并联合直接支架置入术是预防慢血流和无复流现象的一种安全有效的策略。
Recent Pat Cardiovasc Drug Discov. 2012 Aug;7(2):152-9. doi: 10.2174/157489012801227265.
6
The stress hyperglycemic ratio can predict the no-reflow phenomenon following saphenous vein graft intervention in patients with acute coronary syndrome.应激性高血糖比值可预测急性冠脉综合征患者行隐静脉旁路移植介入术后无复流现象。
Acta Diabetol. 2024 Mar;61(3):333-341. doi: 10.1007/s00592-023-02201-0. Epub 2023 Nov 2.
7
Usefulness of The C-Reactive Protein/Albumin Ratio for Predicting No-Reflow in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.C 反应蛋白/白蛋白比值在预测行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死无复流中的作用。
Eur J Clin Invest. 2018 Jun;48(6):e12928. doi: 10.1111/eci.12928. Epub 2018 Apr 17.
8
C-Reactive Protein to Albumin Ratio in Patients With Saphenous Vein Graft Disease.C-反应蛋白与白蛋白比值在大隐静脉移植病变患者中的应用。
Angiology. 2021 Sep;72(8):770-775. doi: 10.1177/0003319721998863. Epub 2021 Mar 8.
9
[A prospective study on the safety and efficacy of excimer laser coronary angioplasty for the treatment of degenerated great saphenous vein graft].准分子激光冠状动脉成形术治疗退化大隐静脉移植血管的安全性和有效性前瞻性研究
Zhonghua Xin Xue Guan Bing Za Zhi. 2023 May 24;51(5):490-496. doi: 10.3760/cma.j.cn112148-20220815-00631.
10
Relationship between plaque composition by virtual histology intravascular ultrasound and clinical outcomes after percutaneous coronary intervention in saphenous vein graft disease patients: study protocol of a prospective cohort study.基于虚拟组织学血管内超声的斑块成分与经皮冠状动脉介入治疗后静脉桥病变患者临床结局的关系:一项前瞻性队列研究的研究方案。
BMC Cardiovasc Disord. 2018 Dec 12;18(1):233. doi: 10.1186/s12872-018-0975-1.

引用本文的文献

1
Prognostic value of the C-reactive protein to albumin ratio in patients with stroke: a meta-analysis.C反应蛋白与白蛋白比值在卒中患者中的预后价值:一项荟萃分析
Sci Rep. 2025 Jul 1;15(1):21150. doi: 10.1038/s41598-025-07327-5.
2
Association Between the Serum Uric Acid to Albumin Ratio and the No-Reflow Phenomenon After Percutaneous Coronary Intervention (PCI): A Systematic Review and Meta-Analysis.血清尿酸与白蛋白比值与经皮冠状动脉介入治疗(PCI)后无复流现象的关联:一项系统评价和荟萃分析
Cureus. 2025 Apr 4;17(4):e81712. doi: 10.7759/cureus.81712. eCollection 2025 Apr.
3
PCSK-9 Inhibitors Can Significantly Improve the Coronary Slow Flow Caused by Elevated Lipoprotein (a) in ST-Elevation Myocardial Infarction Patients With Chronic Kidney Disease.
前蛋白转化酶枯草溶菌素9(PCSK-9)抑制剂可显著改善慢性肾脏病合并ST段抬高型心肌梗死患者因脂蛋白(a)升高所致的冠状动脉慢血流现象。
Catheter Cardiovasc Interv. 2025 Jul;106(1):396-407. doi: 10.1002/ccd.31543. Epub 2025 Apr 25.
4
A Machine Learning Model for the Prediction of No-Reflow Phenomenon in Acute Myocardial Infarction Using the CALLY Index.一种使用CALLY指数预测急性心肌梗死无复流现象的机器学习模型。
Diagnostics (Basel). 2024 Dec 14;14(24):2813. doi: 10.3390/diagnostics14242813.
5
Predictive value of the Naples prognostic score for no-reflow phenomenon after saphenous vein graft stenting.隐静脉移植血管支架置入术后无复流现象的那不勒斯预后评分的预测价值。
Biomark Med. 2025 Jan;19(1):13-22. doi: 10.1080/17520363.2024.2443383. Epub 2024 Dec 22.
6
Percutaneous Coronary Intervention Induced-No-reflow in Saphenous Vein Grafts.经皮冠状动脉介入治疗所致大隐静脉桥无复流现象
Arq Bras Cardiol. 2024 Sep 23;121(8):e20240317. doi: 10.36660/abc.20240317. eCollection 2024.